Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.

Abstract

Histopathologic examination, angiography, and serum levels of alpha-fetoprotein showed that percutaneous ethanol injection is a valuable treatment of hepatocellular carcinoma. The therapy increased the long-term survival of patients who have this disease.